Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of OC-01 (Varenicline) Nasal Spray on Signs and Symptoms of Dry Eye Disease [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating OC-01 (varenicline) nasal spray for dry eye disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• OC-01 (varenicline nasal spray)

Snippet

Sponsor: Corxel Pharmaceuticals | Conditions: Dry Eye Disease | Phase 3 | Status: COMPLETED